Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

ACADIA Pharmaceuticals Net Income 2006-2021 | ACAD

For a detailed definition, formula and example for Net Income, check out our new background page here.
ACADIA Pharmaceuticals net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
ACADIA Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-282
2019 $-235
2018 $-245
2017 $-289
2016 $-271
2015 $-164
2014 $-92
2013 $-38
2012 $-21
2011 $-23
2010 $15
2009 $-45
2008 $-64
2007 $-56
2006 $-45
2005 $-34
ACADIA Pharmaceuticals Quarterly Net Income
(Millions of US $)
2021-03-31 $-66
2020-12-31 $-67
2020-09-30 $-85
2020-06-30 $-42
2020-03-31 $-88
2019-12-31 $-53
2019-09-30 $-42
2019-06-30 $-55
2019-03-31 $-85
2018-12-31 $-65
2018-09-30 $-62
2018-06-30 $-63
2018-03-31 $-54
2017-12-31 $-69
2017-09-30 $-65
2017-06-30 $-67
2017-03-31 $-88
2016-12-31 $-79
2016-09-30 $-72
2016-06-30 $-71
2016-03-31 $-50
2015-12-31 $-46
2015-09-30 $-39
2015-06-30 $-39
2015-03-31 $-40
2014-12-31 $-28
2014-09-30 $-25
2014-06-30 $-21
2014-03-31 $-18
2013-12-31 $-12
2013-09-30 $-11
2013-06-30 $-9
2013-03-31 $-6
2012-12-31 $-7
2012-09-30 $-2
2012-06-30 $-5
2012-03-31 $-6
2011-12-31 $-5
2011-09-30 $-5
2011-06-30 $-7
2011-03-31 $-6
2010-12-31 $29
2010-09-30 $-4
2010-06-30 $-4
2010-03-31 $-5
2009-12-31 $-9
2009-09-30 $-9
2009-06-30 $-13
2009-03-31 $-15
2008-12-31 $-14
2008-09-30 $-16
2008-06-30 $-18
2008-03-31 $-16
2007-12-31 $-17
2007-09-30 $-16
2007-06-30 $-11
2007-03-31 $-13
2006-12-31 $-12
2006-09-30 $-11
2006-06-30 $-12
2006-03-31 $-9
2005-12-31 $-10
2005-09-30 $-12
2005-06-30 $-6
2005-03-31 $-6
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.373B $0.442B
Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.471B 10.43
Amgen (AMGN) United States $140.559B 15.17
CSL (CSLLY) Australia $104.678B 0.00
Moderna (MRNA) United States $87.132B 173.60
Gilead Sciences (GILD) United States $86.902B 9.25
Illumina (ILMN) United States $65.798B 94.88
Biogen (BIIB) United States $62.437B 14.29
BioNTech SE (BNTX) Germany $57.922B 42.00
Regeneron Pharmaceuticals (REGN) United States $56.686B 16.23
Vertex Pharmaceuticals (VRTX) United States $56.114B 23.11
Alexion Pharmaceuticals (ALXN) United States $40.223B 15.28
BeiGene (BGNE) Cayman Islands $32.408B 0.00
Seagen (SGEN) United States $28.760B 49.68
Genmab (GMAB) Denmark $28.630B 33.56
Genmab (GNMSF) Denmark $25.912B 5.96
Horizon Therapeutics Public (HZNP) Ireland $21.117B 27.00
Exact Sciences (EXAS) United States $20.914B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.582B 0.00
CureVac (CVAC) Germany $19.775B 0.00
Incyte (INCY) United States $19.250B 38.06
Alnylam Pharmaceuticals (ALNY) United States $19.190B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $16.949B 89.12
Zai Lab (ZLAB) China $16.404B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.848B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.290B 139.45
Novavax (NVAX) United States $15.185B 0.00
Guardant Health (GH) United States $12.184B 0.00
QIAGEN (QGEN) Netherlands $10.879B 19.32
Repligen (RGEN) United States $10.432B 94.06
CRISPR Therapeutics AG (CRSP) Switzerland $9.373B 0.00
Denali Therapeutics (DNLI) United States $8.994B 322.65
Mirati Therapeutics (MRTX) United States $8.728B 0.00
Fate Therapeutics (FATE) United States $8.315B 0.00
Acceleron Pharma (XLRN) United States $7.944B 0.00
Exelixis (EXEL) United States $7.192B 114.75
Sarepta Therapeutics (SRPT) United States $6.920B 0.00
Ascendis Pharma (ASND) Denmark $6.902B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.733B 0.00
AbCellera Biologics (ABCL) $6.730B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.705B 0.00
Vir Biotechnology (VIR) United States $6.038B 0.00
Halozyme Therapeutics (HALO) United States $5.940B 32.59
SWEDISH ORP BIO (BIOVF) Sweden $5.677B 20.57
Intellia Therapeutics (NTLA) United States $5.667B 0.00
Beam Therapeutics (BEAM) United States $5.501B 0.00
Legend Biotech (LEGN) United States $5.465B 0.00
Twist Bioscience (TWST) United States $5.460B 0.00
Adaptive Biotechnologies (ADPT) United States $5.321B 0.00
I-Mab (IMAB) China $5.309B 0.00
Reata Pharmaceuticals (RETA) United States $5.297B 0.00
Galapagos (GLPG) Belgium $5.285B 0.00
NeoGenomics (NEO) United States $5.056B 857.40
Blueprint Medicines (BPMC) United States $4.907B 14.94
Apellis Pharmaceuticals (APLS) United States $4.903B 0.00
Certara (CERT) United States $4.155B 0.00
SpringWorks Therapeutics (SWTX) United States $4.120B 0.00
Arvinas (ARVN) United States $4.055B 0.00
Alkermes (ALKS) Ireland $4.035B 0.00
Arena Pharmaceuticals (ARNA) United States $3.925B 0.00
Intra-Cellular Therapies (ITCI) United States $3.518B 0.00
Emergent Biosolutions (EBS) United States $3.509B 6.99
Berkeley Lights (BLI) United States $3.155B 0.00
Insmed (INSM) United States $3.009B 0.00
Amicus Therapeutics (FOLD) United States $2.850B 0.00
MorphoSys AG (MOR) Germany $2.830B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
Vericel (VCEL) United States $2.673B 720.75
Global Blood Therapeutics (GBT) United States $2.595B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.581B 0.00
Sorrento Therapeutics (SRNE) United States $2.509B 0.00
Editas Medicine (EDIT) United States $2.503B 0.00
ALX Oncology Holdings (ALXO) United States $2.455B 0.00
Kymera Therapeutics (KYMR) United States $2.339B 0.00
Bluebird Bio (BLUE) United States $2.286B 0.00
Myriad Genetics (MYGN) United States $2.258B 0.00
Myovant Sciences (MYOV) United Kingdom $2.184B 0.00
Morphic Holding (MORF) United States $2.176B 0.00
Instil Bio (TIL) United States $2.156B 0.00
Heska (HSKA) United States $2.148B 936.59
Revance Therapeutics (RVNC) United States $2.133B 0.00
Bionano Genomics (BNGO) United States $2.130B 0.00
Atea Pharmaceuticals (AVIR) United States $2.075B 0.00
Seer (SEER) $2.071B 0.00
Ligand Pharmaceuticals (LGND) United States $2.012B 33.66
Deciphera Pharmaceuticals (DCPH) United States $1.986B 0.00
Prothena (PRTA) Ireland $1.967B 0.00
Amarin (AMRN) Ireland $1.926B 0.00
Inovio Pharmaceuticals (INO) United States $1.916B 0.00
Seres Therapeutics (MCRB) United States $1.878B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.857B 0.00
C4 Therapeutics (CCCC) United States $1.814B 0.00
Castle Biosciences (CSTL) United States $1.785B 0.00
Arcus Biosciences (RCUS) United States $1.766B 0.00
Zymeworks (ZYME) Canada $1.735B 0.00
Genetron Holdings (GTH) China $1.719B 0.00
BioAtla (BCAB) United States $1.717B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.714B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
UniQure (QURE) Netherlands $1.687B 0.00
PureTech Health (PRTC) United States $1.651B 0.00
PHARMA MAR SA (PHMMF) Spain $1.635B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.635B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Alector (ALEC) United States $1.548B 0.00
Cytokinetics (CYTK) United States $1.544B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.531B 0.00
Protagonist Therapeutics (PTGX) United States $1.487B 0.00
Precigen (PGEN) United States $1.443B 0.00
Codexis (CDXS) United States $1.410B 0.00
NGM Biopharmaceuticals (NGM) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.383B 0.00
Avid Bioservices (CDMO) United States $1.381B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.329B 0.00
Northwest Biotherapeutics (NWBO) United States $1.327B 0.00
Ocugen (OCGN) United States $1.326B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.312B 0.00
Nurix Therapeutics (NRIX) United States $1.296B 0.00
Repare Therapeutics (RPTX) Canada $1.254B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.245B 0.00
Keros Therapeutics (KROS) United States $1.224B 0.00
Shattuck Labs (STTK) United States $1.213B 0.00
Celldex Therapeutics (CLDX) United States $1.211B 0.00
MiMedx (MDXG) United States $1.204B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Curis (CRIS) United States $1.161B 0.00
Agenus (AGEN) United States $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.134B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.067B 33.70
Dynavax Technologies (DVAX) United States $1.065B 0.00
Coherus BioSciences (CHRS) United States $1.062B 0.00
VBI Vaccines (VBIV) United States $1.045B 0.00
Mersana Therapeutics (MRSN) United States $1.043B 0.00
Mesoblast (MESO) Australia $1.034B 0.00
Scholar Rock Holding (SRRK) United States $1.022B 0.00
MannKind (MNKD) United States $1.004B 0.00
Avidity Biosciences (RNA) United States $0.950B 0.00
G1 THERAPEUTICS (GTHX) United States $0.922B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.917B 0.00
Cel-Sci (CVM) United States $0.911B 0.00
Merus (MRUS) Netherlands $0.907B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.894B 0.00
Inhibrx (INBX) United States $0.893B 0.00
Travere Therapeutics (TVTX) United States $0.883B 0.00
Sutro Biopharma (STRO) United States $0.867B 0.00
Epizyme (EPZM) United States $0.865B 0.00
Prometheus Biosciences (RXDX) United States $0.826B 0.00
Nkarta (NKTX) United States $0.826B 0.00
Affimed (AFMD) Germany $0.806B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.778B 0.00
Pharming Group (PHAR) Netherlands $0.771B 0.00
Verastem (VSTM) United States $0.756B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
SESEN BIO, INC (SESN) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.724B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.723B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.713B 0.00
IDEAYA Biosciences (IDYA) United States $0.713B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.711B 0.00
Clene (CLNN) United States $0.706B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.699B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Cara Therapeutics (CARA) United States $0.694B 60.26
ChromaDex (CDXC) United States $0.681B 0.00
Precision BioSciences (DTIL) United States $0.675B 0.00
AnaptysBio (ANAB) United States $0.668B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
DBV Technologies S.A (DBVT) France $0.655B 0.00
Anika Therapeutics (ANIK) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Orchard Therapeutics (ORTX) United Kingdom $0.641B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.630B 0.00
ALBIREO PHARMA (ALBO) United States $0.627B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.625B 0.00
Clovis Oncology (CLVS) United States $0.624B 0.00
Bolt Biotherapeutics (BOLT) United States $0.605B 0.00
Adagene (ADAG) China $0.598B 0.00
Codiak BioSciences (CDAK) United States $0.590B 0.00
Compugen (CGEN) Israel $0.571B 0.00
Inventiva S.A (IVA) France $0.566B 0.00
Selecta Biosciences (SELB) United States $0.561B 0.00
Forte Biosciences (FBRX) United States $0.554B 0.00
AC Immune SA (ACIU) Switzerland $0.524B 0.00
Starpharma Holdings (SPHRY) Australia $0.519B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.517B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.513B 0.00
XBiotech (XBIT) United States $0.512B 0.00
Gritstone Bio (GRTS) United States $0.502B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.483B 0.00
Geron (GERN) United States $0.475B 0.00
Athenex (ATNX) United States $0.472B 0.00
CytomX Therapeutics (CTMX) United States $0.469B 0.00
Spero Therapeutics (SPRO) United States $0.468B 0.00
RAPT THERAPTICS (RAPT) United States $0.467B 0.00
Puma Biotechnology (PBYI) United States $0.460B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.456B 0.00
Neoleukin Therapeutics (NLTX) United States $0.450B 0.00
Oncobiologics (OTLK) United States $0.446B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
AquaBounty Technologies (AQB) United States $0.440B 0.00
ANI Pharmaceuticals (ANIP) United States $0.435B 12.02
Cue Biopharma (CUE) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
Fortress Biotech (FBIO) United States $0.418B 0.00
Kala Pharmaceuticals (KALA) United States $0.412B 0.00
Angion Biomedica (ANGN) United States $0.403B 0.00
Opthea (OPT) Australia $0.389B 0.00
Adicet Bio (ACET) United States $0.379B 0.00
SQZ Biotechnologies (SQZ) United States $0.376B 0.00
WAVE Life Sciences (WVE) Singapore $0.372B 0.00
Syros Pharmaceuticals (SYRS) United States $0.364B 0.00
UROGEN PHARMA (URGN) United States $0.362B 0.00
BioDelivery Sciences (BDSI) United States $0.362B 14.68
Athersys (ATHX) United States $0.360B 0.00
Adverum Biotechnologies (ADVM) United States $0.358B 0.00
XOMA (XOMA) United States $0.345B 161.10
IBio (IBIO) United States $0.344B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Theratechnologies (THTX) Canada $0.333B 0.00
Frequency Therapeutics (FREQ) United States $0.331B 0.00
Innate Pharma S.A (IPHA) France $0.326B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.321B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
Kaleido Biosciences (KLDO) $0.314B 0.00
CorMedix Inc (CRMD) United States $0.309B 0.00
Cogent Biosciences (COGT) United States $0.307B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
Cardiff Oncology (CRDF) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
Fulcrum Therapeutics (FULC) United States $0.295B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Bellus Health (BLU) Canada $0.274B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.274B 0.00
Talis Biomedical (TLIS) United States $0.266B 0.00
Kamada (KMDA) Israel $0.265B 18.03
Seelos Therapeutics (SEEL) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.261B 0.00
INmune Bio (INMB) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Chiasma (CHMA) United States $0.241B 0.00
Checkpoint Therapeutics (CKPT) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
NextCure (NXTC) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.227B 0.00
X4 Pharmaceuticals (XFOR) United States $0.223B 0.00
Aptinyx (APTX) United States $0.219B 0.00
VTv Therapeutics (VTVT) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
Synlogic (SYBX) United States $0.192B 0.00
TELA Bio (TELA) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
VolitionRX (VNRX) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 4.70
Applied Genetic Technologies (AGTC) United States $0.183B 0.00
ObsEva SA (OBSV) Switzerland $0.181B 0.00
Clearside Biomedical (CLSD) United States $0.179B 0.00
Nicox SA (NICXF) France $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Galena Biopharma (SLS) United States $0.170B 0.00
Antibe Therapeutics (ATBPF) Canada $0.164B 0.00
Enzo Biochem (ENZ) United States $0.164B 48.57
Yumanity Therapeutics (YMTX) United States $0.162B 0.00
Eton Pharmaceuticals (ETON) United States $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.156B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Exicure (XCUR) United States $0.153B 0.00
Liminal BioSciences (LMNL) Canada $0.144B 0.00
Catalyst Biosciences (CBIO) United States $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.143B 0.00
Cyclerion Therapeutics (CYCN) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.141B 0.00
Eyenovia (EYEN) United States $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.137B 0.00
Orgenesis (ORGS) United States $0.136B 278.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.136B 0.00
Erytech Pharma SA (ERYP) France $0.136B 0.00
Novogen (KZIA) Australia $0.134B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.134B 0.00
Aytu BioPharma (AYTU) United States $0.134B 0.00
ABVC BioPharma (ABVC) United States $0.128B 0.00
Longeveron (LGVN) United States $0.126B 0.00
Vascular Biogenics (VBLT) Israel $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.121B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.117B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
CytRx (CYTR) United States $0.113B 0.00
Celsion (CLSN) United States $0.113B 0.00
Vyant Bio (VYNT) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.108B 0.00
Evofem Biosciences (EVFM) United States $0.108B 0.00
Beyond Air (XAIR) United States $0.108B 0.00
Armata Pharmaceuticals (ARMP) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
Zosano Pharma (ZSAN) United States $0.099B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.097B 0.00
AIkido Pharma (AIKI) United States $0.096B 0.00
Protalix BioTherapeutics (PLX) Israel $0.095B 0.00
Evogene (EVGN) Israel $0.095B 0.00
Lumos Pharma (LUMO) United States $0.093B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.092B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Celyad SA (CYAD) Belgium $0.085B 0.00
Cleveland BioLabs (CBLI) United States $0.085B 0.00
ARIDIS PHARMACT (ARDS) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
ATyr Pharma (LIFE) United States $0.077B 0.00
BioCardia (BCDA) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Advaxis (ADXS) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Cyclo Therapeutics (CYTH) United States $0.064B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.064B 0.00
AEterna Zentaris (AEZS) United States $0.064B 0.00
Viridian Therapeutics (VRDN) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Windtree Therapeutics (WINT) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Invo BioScience (INVO) United States $0.050B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Timber Pharmaceuticals (TMBR) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Benitec Biopharma (BNTC) United States $0.038B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.87
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00